Status:
COMPLETED
Therapeutic Neuroscience Education in Individuals With Fibromyalgia
Lead Sponsor:
Pamukkale University
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
The aim of this study was to investigate the effects of Therapeutic Neuroscience Education (TNE) in individuals with Fibromyalgia (FM). The study included 25 females with FM, randomly separated into t...
Eligibility Criteria
Inclusion
- age between 18-65 years,
- female gender,
- a VAS of at least 40mm to report the pain intensity of the last week,
- having been diagnosed with FM for at least 1 year to present a range of somatic and cognitive symptoms in addition to widespread pain,
- using a fixed dose of medication for at least the past 6 months (serotonin noradrenaline reuptake inhibitors \[Ex, duloxetine, milnacipran\]; alpha 2-delta receptor ligand \[Ex, pregabalin\]; gabapentinoids).
Exclusion
- the presence of another disease which may affect the physical condition,
- cognitive impairment at a level preventing cooperation,
- being pregnant,
- inability to understand or speak Turkish,
- concurrent autoimmune or inflammatory disease,
- the presence of a central nervous system disease (eg multiple sclerosis, Parkinson's disease),
- serious psychiatric conditions (eg, psychotic disorders) that would prevent participation,
- participation in a rehabilitation program in the past year,
- have been exercising regularly for 6 months,
- not participating in at least 75% of treatments.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05435807
Start Date
June 1 2019
End Date
June 15 2021
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Merkezefendi, Turkey (Türkiye), 20070